Research and Clinical Trials

Helping people to take their medication appropriately is one of the most
important things we can do as a nation and as part of our
broader healthcare strategy.

- Valerie Fleishman, Executive Director of the NEHI

Institutions

Analogously to patients and caregivers within the home environment, reminder and pill management systems play key roles for pharmaceutical and biotechnology institutions while in the all phases (phase I - phase IV) of clinical trial and beyond (phase V). Accurate measurement of drug effectiveness while in clinical trial and assigned to patients outside a controlled environment is paramount for maximizing drug effectiveness and overall long-term patient health. There is a proven medication adherence gap between subjects within a laboratory environment and what happens when patients are prescribed the same regimen within their home. This gap, along with the dangers and medical complications which accompany it, exists for patients after the drug's public released as well compounding its significance. It is with this understanding that drives RxPerfect’s team to, with great intent, offer solutions tailored to the patient’s existing health and physical environment. We strive to offer and innovate on products, solutions and support in order to make it possible for our clients and patients to emulate the highly controlled laboratory settings where ideal medication adherence is most prevalent; leading to perfect intake rates and the best possible outcomes for health.

Universities using solutions offered by RxPerfect
Arizona State University • Columbia University • Cornell University • Drake College of Pharmacy • Duke University • Eastern Washington University • Emory University • George Mason University • Husson College • Indiana University • Massachusetts College of Pharmacy • Northern Arizona University • Northwestern University • Purdue University • Southeast Missouri State University • St. John's University • State University of New York Plattsburgh • Temple University • Texas Tech UHSC School of Pharmacy • University of Buffalo • University of California UCSD • University of California UCSF • University of Colorado • University of Florida • University of Iowa • University of Louisville • University of Maryland • University of New Mexico • University of North Carolina • University of Pennsylvania • University of Texas • Washington University in St. Louis • Yale University • Yeshiva University

Institutions using solutions offered by RxPerfect
Abington Memorial Hospital • Abbott Labs • Agouron Pharmaceuticals • Alfred Dupont Hospital for Children • Alkermes • AstraZeneca • Baptist Hospital Waltham • Baystate Health System • Bellevue Hospital Center • Beth Israel Medical Center • Biologics • Black Hawk-Grundy Mental Health Center• Boston Medical Center • Brigham and Women's Hospital • Bristol-Myers Squibb • Brooks Rehabilitation Hospital • Capital District DDSO • Chemung ARC • Chesapeake General Hospital • Chicago Shriners Hospital • Children's Healthcare of Atlanta Egleston • Children's Hospital Boston • Children's Hospital Denver • Clinical Solutions • Conway Regional Health System • Cooper University Hospital • CVS Health Connection • Dartmouth-Hitchcock Medical Center • Dover Rehab • Doylestown Hospital • Driscoll Children's Hospital • Ellis Hospital • Endo Pharmaceuticals • Fisher Scientific • Gillette Childrens Specialty Health Care • Grady Health Systems • GTX • HealthSouth Massachusetts • Healthsouth New Mexico • High Point Regional • Hospital for Special Surgery • Johnson & Johnson Pharmaceutical Research • Joslin Clinic • JSI Research Training Institute • Jupiter Medical Center • Kearny Country Hospital • Maricopa Integrated Health • Marin General Hospital • Massachusetts Eye and Ear Infirmary • Mayo Clinic • Medivation • Merck • Montefiore Medical Center • Northeast Center For Special Care • Northeast Kingdom Human Services • Novartis • Pfizer • Portneuf Valley Hospital • PPD • Queens Health Network • Quintiles • Rice Memorial Hospital • Roche • Sankyo Pharmaceuticals • Schering-Plough • Serono • Southampton General Hospital • Southern Illinois Healthcare Foundation • Spaulding Rehab Hospital • St. Francis Hospital • St. John's Riverside Hospital • St. Jude Childrens Hospital • St. Luke's Regional Medical Center • Texas Commision for the Blind • Trenton Community Clinic • United States Department of the Army • United States Department of Veteran Affairs • Unity Health • University Hospital Southampton • Vanda Pharmaceuticals • Vanderbilt University Medical Center • Vertex Pharmaceuticals • Veteran Affairs Medical Center Albuquerque • Veteran Affairs Medical Center Fargo • Veteran Affairs Medical Center Fort Meade • Veteran Affairs Medical Center Honolulu • Veteran Affairs Medical Center Iowa City • Veteran Affairs Medical Center Minneapolis • Veteran Affairs Medical Center Northport • Veteran Affairs Medical Center Portland • Veteran Affairs Medical Center San Diego • Veteran Affairs Medical Center St. Cloud • Veteran Affairs Medical Center St. Louis • Veteran Affairs Medical Center Tampa • Veteran Affairs Medical Center Walter Reed • Veteran Affairs Medical Center West Palm • Weber Human Services • Westchester Medical Center • York General Hospital • Zinberg Clinic

$290 Billion Annually

NEHI, The Network for Excellence in Health Innovation, an independent nonprofit organization who is in partnership with members from all across healthcare found $290 billion dollars to be the annual cost to the U.S. healthcare system driven solely by medication nonadherence. These costs equating to 13% of our total national healthcare spend take the form of avoidable hospitalizations, avoidable hospital readmission, avoidable nursing home visits, avoidable emergency room visits and disease progression. Premature illness and death combined with the emotional and physical toll that come with not taking medication intelligently adds to the epidemic faced by hundreds of millions of patients globally.

Synergy

Further research show that 25% of patients who are written a new prescription for their current ailment choose not to fill that prescription; and almost 50% or 78 million Americans alone who are taking a drug to treat a chronic condition will stop taking their medication within the first year. Non-coincidentally, the top conditions (high blood pressure, high cholesterol, diabetes and depression) for which medication is prescribed are also the leading conditions where medication nonadherence is most prevalent. With an introduction of a medication reminder into patients’ daily regimen, studies have shown adherence rates leapfrog to 95%. This increase results in improved health, vast reduction in healthcare costs for patients and employers, and enhanced mental health due to lowed emotional stress. The reminder creates synergy within the patient’s life across multiple channels leading to heightened well-being and an overall improved state beyond what medicating alone is capable of.

Studying, understanding and improving on medication adherence is essential to properly managing outcome and costs for patients, employers, hospitals, pharmaceutical and biotechnology institutions.
Significance

When the financial, emotional and physical costs are coupled with the scale, impact and importance of medication nonadherence it has become vastly evident that the field has earned the right for the need to be discussed and addressed by policymakers and healthcare leaders as an issue to stand strongly alongside priorities such as patient safety; not only here in the U.S. but globally as well in order to enrich life across all channels.

For peace of mind and better health;
"Be Smart. Be Safe." - Erik S. Solvell, Founder & President | RxPerfect.com